Get started
Author

Hilary R. Teaford

Observed name: Hilary Teaford
Institution: Mayo Clinic
ORCID: 0000-0002-2120-7380
Observed ORCID: 0000-0002-2120-7380
OpenAlex ID: A5017429908
Escaping the professional silo: an escape room implemented in an interprofessional education curriculum
2018 · Cheri Friedrich, Hilary Teaford, et al. · Journal of Interprofessional Care · 133
Cystatin C: A Primer for Pharmacists
2020 · Hilary R. Teaford, Jason N. Barreto, et al. · Pharmacy · 59
PDF
Interprofessional Health Care Escape Room for Advanced Learners
2020 · Cheri Friedrich, Hilary Teaford, et al. · Journal of Nursing Education · 50
The Many Faces of Itraconazole Cardiac Toxicity
2020 · Hilary R. Teaford, Omar M. Abu Saleh, et al. · Mayo Clinic Proceedings Innovations Quality & Outcomes · 40
Patterns of Cystatin C Uptake and Use Across and Within Hospitals
2020 · Hilary R. Teaford, Andrew D. Rule, et al. · Mayo Clinic Proceedings · 27
Clinician perspectives on inpatient cystatin C utilization: A qualitative case study at Mayo Clinic
2020 · James Roland Markos, Karen S. Schaepe, et al. · PLoS ONE · 15
PDF
Prediction of Vancomycin Levels Using Cystatin C in Overweight and Obese Patients: a Retrospective Cohort Study of Hospitalized Patients
2020 · Hilary R. Teaford, Ryan W. Stevens, et al. · Antimicrobial Agents and Chemotherapy · 12
Challenges in renally eliminated medication use: Evaluating cystatin C and serum creatinine eGFR discordance
2024 · Brandy N. Hernandez, Patrick M. Wieruszewski, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 7
PDF
Comparable outcomes of outpatient remdesivir and sotrovimab among high-risk patients with mild to moderate COVID-19 during the omicron BA.1 surge
2024 · Supavit Chesdachai, Christina G. Rivera, et al. · Scientific Reports · 4
PDF
Enterprise standardization and convergence of large-volume infusion pump drug libraries
2023 · Samuel Ubanyionwu, Divya Khandekar, et al. · American Journal of Health-System Pharmacy · 3
Impact of pharmacist-led microbiology result follow-up post-discharge for patients undergoing inpatient infectious diseases consultation
2024 · Amy L. Van Abel, Abinash Virk, et al. · Antimicrobial Stewardship & Healthcare Epidemiology · 2
PDF
System-wide approach on biosimilars adoption in oncology: Strategic plan on switching and cost savings.
2023 · Suwicha Limvorasak, Kyung Kim, et al. · Journal of Clinical Oncology · 1
PDF
Successful biosimilar adoption in oncology: strategic approach to system standardization.
2022 · Suwicha Limvorasak, Crystal Leung Dobbs, et al. · Journal of Clinical Oncology · 1
Implementation of a novel process for post-discharge microbiology results review for musculoskeletal infections in a large-volume academic healthcare system
2025 · Margaret Pertzborn, Amy L. Van Abel, et al. · Journal of Bone and Joint Infection
PDF
QIM22-198: Optimizing a Systemic Platform to Standardize Oncologic Biosimilars Utilization at Cedars-Sinai Medical Center (CSMC)
2022 · Suwicha Limvorasak, Hilary Teaford, et al. · Journal of the National Comprehensive Cancer Network
Works count: 15
Citation count: 354
H-index: 7
I10-index: 7
Year
Topic
Type